Research Institute / East Carolina University / Memorial Sloan-Kettering Cancer Center / University of Utah / Johns Hopkins University / University of Michigan / University of California / Nationwide Children’s Hospital / /
IndustryTerm
prevention of prostate cancer / prostate cancer treatment / /
MedicalCondition
tumor / ovarian cancers / breast cancers / prostate cancer metastasis / docetaxel-resistant / metastatic castration-resistant prostate cancer / bone resorption / prostate cancer / metastatic breast cancers / /
MedicalTreatment
surgery / /
Organization
East Carolina University / Research Institute / University of Utah / School of Medicine / Coordinating Center / University of Michigan / Memorial Sloan-Kettering Cancer Center / FDA / University of California / Los Angeles / Johns Hopkins University / Nationwide Children’s Hospital / /
Person
Evan Keller / Damien Pearse / Howard Scher / Susan Neuhausen / Kathryn Verbanac / Dennis Slamon / /
Position
Principal Investigator / Mouse Model for Schwannomatosis / /
CDMRP “Game-Changing” Products Clicking on the link will take you to the project’s Abstract. Breast Cancer Research Program Dr. Dennis Slamon, University of California, Los Angeles: Herceptin®, a monoclonal antibo